A.P. Pharma, Inc. (NASDAQOTCBB:APPA)
CAPS Rating:
A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.
A specialty pharmaceutical company focused on developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.
Recs
This stock was listed on the "pumps and dumps" watch list.